+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biodegradable Coronary Stents Market - Global Forecast 2026-2032- Product Image
Biodegradable Coronary Stents Market - Global Forecast 2026-2032- Product Image
Sale

Biodegradable Coronary Stents Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6124076
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biodegradable Coronary Stents Market is projected to reach USD 1.52 Billion in 2026. It is expected to continue growing at a CAGR of 6.79%, reaching USD 2.24 Billion by 2032.

Biodegradable Coronary Stents: Executive Overview

Biodegradable coronary stents are designed to provide temporary vessel support and drug delivery before gradually resorbing. Their clinical value proposition centers on reducing the long-term presence of permanent implants, which may support more natural vascular function and simplify future interventions. Adoption remains closely tied to evidence on safety, efficacy, degradation behavior, deliverability, and reimbursement.

Clinical Evidence and Device Design Are Reshaping Adoption

The landscape is shifting from permanent metallic scaffolds toward solutions that seek to balance short-term mechanical support with long-term biological compatibility. Important design priorities include predictable degradation, adequate radial strength, controlled drug release, low thrombogenicity, and reliable deployment. Regulators, clinicians, and hospital buyers increasingly emphasize rigorous comparative evidence, standardized endpoints, and post-market monitoring before broader use.

Artificial Intelligence Strengthens Development, Selection, and Follow-Up

Artificial intelligence can contribute across the device lifecycle without replacing clinical validation. Machine-learning tools may assist lesion and vessel assessment, imaging interpretation, patient-risk stratification, trial recruitment, and individualized procedural planning. In manufacturing and quality management, AI can support process monitoring and defect detection. Its practical impact depends on representative datasets, explainability, cybersecurity, clinician oversight, and compliance with medical-device requirements.

Regional Insights: Evidence, Access, and Infrastructure Shape Adoption

North America is influenced by demanding clinical-evidence standards, advanced interventional cardiology capacity, and reimbursement scrutiny. Latin America presents opportunities linked to growing cardiovascular-care needs, while affordability, procurement, and uneven specialist access remain important considerations. Europe is shaped by coordinated regulatory and health-technology-assessment expectations, with the European Union emphasizing evidence, safety, and value. The Middle East is investing in specialized healthcare infrastructure, particularly in major urban centers, while the broader region requires attention to referral pathways and affordability. Africa faces substantial variation in catheterization capacity, trained personnel, and device access. Asia-Pacific combines advanced capabilities in countries such as Japan, Australia, and South Korea with rapidly expanding cardiac-care systems elsewhere, making local evidence, training, and distribution critical.

Group Insights: Policy Alignment and Procurement Networks Matter

ASEAN markets differ considerably in regulatory maturity, hospital capability, and reimbursement, so regional cooperation and clinician training can reduce adoption barriers. BRICS economies bring large and diverse patient populations, alongside varied domestic manufacturing, approval, and public-procurement systems. The European Union benefits from shared policy frameworks but still experiences national differences in reimbursement and hospital adoption. G7 countries generally combine sophisticated research and clinical infrastructure with stringent evidence expectations. GCC states often have concentrated, well-equipped healthcare systems and can serve as specialized-care hubs, while NATO members show diverse national pathways for regulation, procurement, and cardiovascular service delivery.

Country Insights: National Systems Create Distinct Adoption Pathways

Australia combines strong clinical governance with geographically dispersed care delivery. Brazil and Mexico must address regional disparities, public-sector procurement, and specialist access. Canada and the United States maintain advanced interventional capabilities, with adoption shaped by evidence, reimbursement, and hospital protocols. China and India have expanding cardiovascular-care capacity but require attention to affordability, domestic evidence, and uneven access. Japan and South Korea emphasize technical quality, aging-population needs, and careful clinical evaluation. France, Germany, Italy, Spain, and the United Kingdom operate within mature European healthcare environments, yet reimbursement, assessment, and procurement decisions remain nationally differentiated. Russia’s pathway is influenced by domestic healthcare priorities, regulatory processes, and access to specialized technology.

Actions for Leaders: Build Evidence, Resilience, and Clinical Confidence

Industry leaders should prioritize well-designed clinical studies with meaningful patient and imaging endpoints, transparent long-term follow-up, and clear comparisons with established treatments. Product development should integrate degradation kinetics, deliverability, imaging visibility, and manufacturing consistency from the outset. Market access planning should map country-specific regulatory, reimbursement, and procurement requirements rather than rely on a single global pathway. Leaders should also invest in physician training, center-of-excellence partnerships, supply-chain resilience, cybersecurity, and carefully governed AI tools that improve workflow without obscuring clinical accountability.

Research Methodology: Structured Review of Clinical and Health-System Evidence

This executive summary is based on a structured assessment of the biodegradable coronary stent field, including device-function principles, clinical adoption requirements, regulatory considerations, healthcare-system characteristics, and regional access conditions. The analysis organizes insights across the required regions, economic and political groupings, and countries, while separating established characteristics from areas requiring further validation. It excludes market estimates, market shares, forecasts, and company-specific claims, and emphasizes evidence quality, implementation conditions, and decision-relevant themes.

Conclusion: Adoption Depends on Demonstrated Long-Term Value

Biodegradable coronary stents offer a clinically meaningful alternative to permanent scaffolds, but their acceptance depends on demonstrating durable patient benefit alongside dependable procedural performance. Progress will be strongest where device engineering, clinical evidence, regulatory strategy, reimbursement planning, and physician education advance together. Regional and national differences make adaptable implementation essential, while responsible use of artificial intelligence can improve development and care when supported by robust data and human oversight.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biodegradable Coronary Stents Market, by Material
7.1. Introduction
7.2. Iron
7.3. Magnesium
7.4. Polymer
7.4.1. Pdlla
7.4.2. Plla
8. Biodegradable Coronary Stents Market, by Application
8.1. Introduction
8.2. Acute Coronary Syndrome
8.3. Stable Angina
9. Biodegradable Coronary Stents Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.2.1. Hospital-Owned Ambulatory Surgical Centers
9.2.2. Independent Ambulatory Surgical Centers
9.3. Hospitals
9.3.1. Cardiac Centers
9.3.2. Multi-Specialty Hospitals
10. Biodegradable Coronary Stents Market, by Distribution Channel
10.1. Introduction
10.2. Direct Tender
10.3. Third Party Distributor
11. Biodegradable Coronary Stents Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Biodegradable Coronary Stents Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Biodegradable Coronary Stents Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Amaran Biotechnology Co., Ltd.
15.3. Amendia, Inc.
15.4. Arterial Remodeling Technologies, Inc.
15.5. Biomedical Structures, Inc.
15.6. Biotronik SE & Co. KG
15.7. Boston Scientific Corporation
15.8. Cook Medical LLC
15.9. Cordis Corporation
15.10. Elixir Medical Corporation
15.11. Endologix, Inc.
15.12. HeartFlow, Inc.
15.13. Hengrui Medicine Co., Ltd.
15.14. Inflow Dynamics Corp.
15.15. Johnson & Johnson Services, Inc.
15.16. Lepu Medical Technology (Beijing) Co., Ltd.
15.17. Meril Life Sciences Pvt. Ltd.
15.18. OrbusNeich Medical Company
15.19. Reva Medical, Inc.
15.20. Shanghai MicroPort Medical (Group) Co., Ltd.
15.21. Sino Medical Sciences Technology Inc.
15.22. Svelte Medical Systems Ltd.
15.23. Terumo Corporation
15.24. Translumina GmbH
15.25. Xeltis AG
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Biodegradable Coronary Stents Market, Years Considered for the Study
FIGURE 2. Global Biodegradable Coronary Stents Market, Research Design
FIGURE 3. Global Biodegradable Coronary Stents Market, Research Framework
FIGURE 4. Global Biodegradable Coronary Stents Market, Data Triangulation
FIGURE 5. Global Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Biodegradable Coronary Stents Market Size, by Material, 2025 vs 2032 (%)
FIGURE 7. Global Biodegradable Coronary Stents Market Size, by Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Biodegradable Coronary Stents Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Biodegradable Coronary Stents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Biodegradable Coronary Stents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Biodegradable Coronary Stents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Biodegradable Coronary Stents Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Biodegradable Coronary Stents Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Biodegradable Coronary Stents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Biodegradable Coronary Stents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Biodegradable Coronary Stents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Biodegradable Coronary Stents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Biodegradable Coronary Stents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Biodegradable Coronary Stents Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Biodegradable Coronary Stents Market Segmentation & Coverage
TABLE 2. Global Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 3. Global Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 4. Global Iron Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Iron Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Iron Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Magnesium Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Magnesium Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Magnesium Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pdlla Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pdlla Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pdlla Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Plla Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Plla Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Plla Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 20. Global Acute Coronary Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Acute Coronary Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Acute Coronary Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Stable Angina Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Stable Angina Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Stable Angina Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 27. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Hospital-Owned Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Hospital-Owned Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Hospital-Owned Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Independent Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Independent Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Independent Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Cardiac Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Cardiac Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Cardiac Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Multi-Specialty Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Multi-Specialty Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Multi-Specialty Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 46. Global Direct Tender Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Direct Tender Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Direct Tender Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Third Party Distributor Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Third Party Distributor Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Third Party Distributor Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Biodegradable Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Biodegradable Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 61. North America Biodegradable Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. North America Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 63. North America Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 64. North America Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 65. North America Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 66. North America Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 67. North America Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 68. North America Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 69. Latin America Biodegradable Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Latin America Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 71. Latin America Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 72. Latin America Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 73. Latin America Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 74. Latin America Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 75. Latin America Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 76. Latin America Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 77. Europe Biodegradable Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Europe Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 79. Europe Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 80. Europe Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. Europe Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Europe Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 83. Europe Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 84. Europe Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 85. Middle East Biodegradable Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Middle East Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 87. Middle East Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 88. Middle East Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Middle East Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. Middle East Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 91. Middle East Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 92. Middle East Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 93. Africa Biodegradable Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Africa Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 95. Africa Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 96. Africa Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. Africa Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. Africa Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 99. Africa Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 100. Africa Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 101. Global Biodegradable Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. ASEAN Biodegradable Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. ASEAN Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 104. ASEAN Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 105. ASEAN Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. ASEAN Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. ASEAN Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 108. ASEAN Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 109. ASEAN Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 110. GCC Biodegradable Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. GCC Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 112. GCC Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 113. GCC Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. GCC Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. GCC Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 116. GCC Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 117. GCC Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 118. European Union Biodegradable Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. European Union Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 120. European Union Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 121. European Union Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. European Union Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. European Union Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 124. European Union Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 125. European Union Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 126. BRICS Biodegradable Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. BRICS Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 128. BRICS Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 129. BRICS Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. BRICS Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. BRICS Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 132. BRICS Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 133. BRICS Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. G7 Biodegradable Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. G7 Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 136. G7 Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 137. G7 Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. G7 Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. G7 Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 140. G7 Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 141. G7 Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. NATO Biodegradable Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. NATO Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 144. NATO Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 145. NATO Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. NATO Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. NATO Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 148. NATO Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 149. NATO Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 150. Global Biodegradable Coronary Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. United States Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 152. United States Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 153. United States Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 154. United States Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. United States Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. United States Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 157. United States Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 158. United States Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 159. Canada Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 160. Canada Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 161. Canada Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 162. Canada Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. Canada Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Canada Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 165. Canada Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 166. Canada Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. Mexico Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 168. Mexico Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 169. Mexico Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 170. Mexico Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. Mexico Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Mexico Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 173. Mexico Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 174. Mexico Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 175. Brazil Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 176. Brazil Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 177. Brazil Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 178. Brazil Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. Brazil Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. Brazil Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 181. Brazil Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 182. Brazil Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 183. United Kingdom Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 184. United Kingdom Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 185. United Kingdom Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 186. United Kingdom Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. United Kingdom Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. United Kingdom Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 189. United Kingdom Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 190. United Kingdom Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 191. Germany Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 192. Germany Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 193. Germany Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 194. Germany Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. Germany Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Germany Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 197. Germany Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 198. Germany Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. France Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 200. France Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 201. France Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 202. France Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. France Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. France Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 205. France Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 206. France Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 207. Russia Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 208. Russia Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 209. Russia Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 210. Russia Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Russia Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. Russia Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 213. Russia Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 214. Russia Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 215. Italy Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 216. Italy Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 217. Italy Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 218. Italy Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. Italy Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Italy Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 221. Italy Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 222. Italy Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 223. Spain Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 224. Spain Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 225. Spain Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 226. Spain Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Spain Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. Spain Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 229. Spain Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 230. Spain Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 231. China Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 232. China Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 233. China Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 234. China Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. China Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. China Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 237. China Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 238. China Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 239. India Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 240. India Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 241. India Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 242. India Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. India Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. India Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 245. India Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 246. India Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 247. Japan Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 248. Japan Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 249. Japan Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 250. Japan Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. Japan Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. Japan Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 253. Japan Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 254. Japan Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 255. Australia Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 256. Australia Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 257. Australia Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 258. Australia Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. Australia Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. Australia Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 261. Australia Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 262. Australia Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 263. South Korea Biodegradable Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 264. South Korea Biodegradable Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 265. South Korea Biodegradable Coronary Stents Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 266. South Korea Biodegradable Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. South Korea Biodegradable Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. South Korea Biodegradable Coronary Stents Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 269. South Korea Biodegradable Coronary Stents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 270. South Korea Biodegradable Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 271. Global Biodegradable Coronary Stents Market Share, by Key Player, 2025
TABLE 272. Global Biodegradable Coronary Stents Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Amaran Biotechnology Co., Ltd.
  • Amendia, Inc.
  • Arterial Remodeling Technologies, Inc.
  • Biomedical Structures, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Cordis Corporation
  • Elixir Medical Corporation
  • Endologix, Inc.
  • HeartFlow, Inc.
  • Hengrui Medicine Co., Ltd.
  • Inflow Dynamics Corp.
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • OrbusNeich Medical Company
  • Reva Medical, Inc.
  • Shanghai MicroPort Medical (Group) Co., Ltd.
  • Sino Medical Sciences Technology Inc.
  • Svelte Medical Systems Ltd.
  • Terumo Corporation
  • Translumina GmbH
  • Xeltis AG

Related Topics

Related Reports

Hydrophilic Coronary Stents Market - Global Forecast 2026-2032 - Product Image

Hydrophilic Coronary Stents Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Cobalt Chromium Coronary Stent Market - Global Forecast 2026-2032 - Product Image

Cobalt Chromium Coronary Stent Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Coronary Stents Market Report 2026 - Product Image

Coronary Stents Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Coronary Stent - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Coronary Stent - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Coronary Stents Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Coronary Stents Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 130 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.